Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Declan Doogan currently holds 30,000 shares of TENAX THERAPEUTICS, INC. (TENX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Declan Doogan has been a net seller of TENX stock. They have purchased $0 and sold $64.2M worth of shares.
Declan Doogan's most recent insider trade was on Jan 9, 2026, when they sold 30,000 shares at $0.00 per share.
Declan Doogan serves as Executive at TENAX THERAPEUTICS, INC. (TENX). They have executed 115 insider transactions totaling $64.2M over their tenure at the company.
Declan Doogan holds the position of Executive at TENAX THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Declan Doogan has shown a selling trading pattern, with $0 in total purchases and $64.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Declan Doogan was on Nov 16, 2021, when they sold $2.1M worth of BHVN shares. This transaction involved 18,230 shares at $116.69 per share.
Declan Doogan currently owns 30,000 shares of TENAX THERAPEUTICS, INC. (TENX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Declan Doogan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Declan Doogan has 115 Form 4 filings on record as an insider at TENAX THERAPEUTICS, INC..
Set alerts for Declan Doogan and 40,000+ other insiders.